Kiadis Pharma is a biopharmaceutical company that develops and commercializes T-cell based immunotherapies for the treatment of blood cancer. Kiadis Pharma was founded in 1997. Kiadis Pharma's headquarters is located in Amsterdam, Zuid-Holland, NL 110...
Kiadis Pharma's CEO, Arthur Lahr, currently has an approval
rating of 86%. Kiadis Pharma's primary competitors are Glycostem, NexImmune & Phio Pharmaceuticals.